US EditionAmerican pharmaceutical duo injects an additional 150 million dollars into Ghent megasite for cancer therapy
Summary by De Tijd
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
American pharmaceutical duo injects an additional 150 million dollars into Ghent megasite for cancer therapy
Johnson & Johnson and Legend Biotech are investing in expanding their mega-production site for blood cancer therapy in Ghent to keep up with demand. It concerns an amount of 150 million dollars (138 million euros).
·Belgium
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
